Welcome to Kinase Logistics Europe
The mission of Kinase Logistics is to provide reagents, service, and technical support for kinase drug development. Kinase Logistics offers high-quality recombinant protein and lipid kinases, kinase assay kits, biochemical and cell-based kinase profiling/screening services, and a solution to investigate protein-protein interaction.
Kinase Logistics has been appointed by Carna Biosciences, Inc., Japan as their European Distributor.
Recombinant Human Wild Type Kinases
Mutant forms, isoforms, and inactive forms
Kinases & Substrates
We offer active recombinant human protein and lipid kinases suited for activity assays, biotinylated kinases suited for binding studies as well as a limited number of inactive or inactive mutant kinases suitable as substrates, and additional recombinant protein substrates.
Assay kits are available for more than 300 human kinase targets and are ready-to-go products for various assay platforms. They are optimized for testing small molecule compounds for inhibitory activity.
Biochemical Profiling Assay Services
Once compounds are identified, mechanism of action studies are necessary to characterize and compare the potential drug candidates. We offer activity-based kinase profiling and screening services for assessing potency and selectivity of your compounds.
Cell-based Assay Services
For more accurate prediction of kinase inhibitor function we offer different cellular kinase assay services for assessing occupancy, selectivity, and affinity of your compounds.
2022 Year-End Campaign
We’ve got good news for you: a special discount for human Kinases from Carna Biosciences.
ACD Fall Campaign - Save 30% on Cell-Based Services & Products
Fall savings are in the air, Save 30% on ACD Cell-Based Services & Products!
DGKα and DGKζ are key targets for cancer immunotherapy
Carna Newsletter Vol.14
The potential of PIKfyve inhibitor as a treatment of amyotrophic lateral sclerosis (ALS)
Carna Newsletter Vol.13
New Website Launch Discount!
We’re extremely pleased to announce the launch of our new website! We decided that it was time for a fresh new look, which surely empowers our…
New Cellular CDK Assay Panel Launched and Special Offers from Carna
We are pleased to launch a new CDK (cyclin-dependent kinases) Cell-based Assay Panel for kinase researchers who are focusing on the CDK family.…
The importance of understanding the activity of compounds on RAF dimerization in BRAF inhibitor drug discovery
Carna Biosciences Newsletter Vol. 12
Kinase Inhibitors as Potential Therapeutic Agents for COVID-19
Carna Biosciences Newsletter Vol. 11